Farxiga and Nitrostat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Farxiga (dapagliflozin) and Nitrostat (nitroglycerin). Common drug interactions include abscess among females and perirectal abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Farxiga and Nitrostat. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Farxiga?

Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. eHealthMe is studying from 18,798 Farxiga users. Check the latest studies of Farxiga.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

64 people who take Farxiga and Nitrostat together, and have interactions are studied.

Farxiga and Nitrostat drug interactions.

What are the common drug interactions of Farxiga and Nitrostat, by gender? *:

female:

  1. Abscess (pus)
  2. Cellulitis (infection under the skin)
  3. Escherichia sepsis (bacterial infection by escherichia coli)
  4. Groin abscess (pus in groin)
  5. Perineal abscess
  6. Tooth abscess (pus formation in tooth)
  7. Vulval abscess
  8. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  9. Chronic kidney disease
  10. Asthenia (weakness)

male:

  1. Perirectal abscess
  2. Chronic kidney disease
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  5. Perineal abscess
  6. Perineal infection
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Scrotal abscess (pus in scrotum)
  9. Wound infection
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Farxiga and Nitrostat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Subcutaneous abscess
  2. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  3. Abscess (pus)
  4. Abscess limb (limb infection)
  5. Cellulitis (infection under the skin)
  6. Escherichia sepsis (bacterial infection by escherichia coli)
  7. Groin abscess (pus in groin)
  8. Perineal abscess
  9. Perirectal abscess
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Hypertension (high blood pressure)
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Perineal abscess
  4. Perineal infection
  5. Scrotal abscess (pus in scrotum)
  6. Abscess limb (limb infection)
  7. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  8. Rectal abscess (pus in rectum)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Injection site pain

60+:

  1. Death
  2. Diarrhoea
  3. Cerebellar ataxia (loss of coordination)
  4. Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
  5. Cerebral disorder (brain disease)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  8. Depression
  9. Diabetes mellitus inadequate control
  10. Encephalomalacia (localized softening of the brain substance, due to haemorrhage or inflammation)

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 18 people, 28.12%
  2. Pain: 7 people, 10.94%
  3. High Blood Pressure: 6 people, 9.38%
  4. High Blood Cholesterol: 6 people, 9.38%
  5. Weight Decreased: 5 people, 7.81%
  6. Prostate Cancer: 4 people, 6.25%
  7. Depression: 4 people, 6.25%
  8. Cardiac Failure Congestive: 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Farxiga and Nitrostat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Farxiga and Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Farxiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Farxiga and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrostat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dapagliflozin and nitroglycerin (the active ingredients of Farxiga and Nitrostat, respectively), and Farxiga and Nitrostat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: